Nurix Therapeutics, Inc. (NRIX)
NASDAQ: NRIX · Real-Time Price · USD
19.83
-0.21 (-1.05%)
Dec 20, 2024, 4:00 PM EST - Market closed
Nurix Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is December - November.
Millions USD. Fiscal year is Dec - Nov.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Dec '24 Dec 20, 2024 | Nov '23 Nov 30, 2023 | Nov '22 Nov 30, 2022 | Nov '21 Nov 30, 2021 | Nov '20 Nov 30, 2020 | Nov '19 Nov 30, 2019 |
| Market Capitalization | 1,405 | 302 | 584 | 1,286 | 1,656 | - | |
| Market Cap Growth | 296.19% | -48.35% | -54.57% | -22.36% | - | - | |
| Enterprise Value | 974 | 41 | 184 | 942 | 1,302 | - | |
| Last Close Price | 19.83 | 6.22 | 12.39 | 28.82 | 42.62 | - | |
| PS Ratio | 21.51 | 3.92 | 15.12 | 43.22 | 92.93 | - | |
| PB Ratio | 3.53 | 1.50 | 1.92 | 3.76 | 5.71 | - | |
| P/TBV Ratio | 4.31 | 1.50 | 1.92 | 3.76 | 5.71 | - | |
| EV/Sales Ratio | 17.27 | 0.53 | 4.76 | 31.66 | 73.05 | - | |
| Debt / Equity Ratio | 0.07 | 0.15 | 0.04 | 0.04 | - | - | |
| Asset Turnover | 0.14 | 0.20 | 0.09 | 0.07 | 0.08 | 0.70 | |
| Quick Ratio | 5.20 | 3.32 | 4.39 | 4.57 | 6.58 | 2.34 | |
| Current Ratio | 5.28 | 3.40 | 4.51 | 4.70 | 6.70 | 2.44 | |
| Return on Equity (ROE) | -57.96% | -57.10% | -55.84% | -37.05% | -30.80% | -2372.77% | |
| Return on Assets (ROA) | -29.46% | -25.10% | -25.72% | -16.88% | -18.44% | -31.07% | |
| Return on Capital (ROIC) | -37.49% | -35.45% | -34.25% | -22.82% | -28.93% | -1519.68% | |
| Earnings Yield | -12.60% | -47.71% | -30.88% | -9.11% | -2.61% | - | |
| FCF Yield | -7.61% | -29.75% | -29.45% | -7.00% | -0.28% | - | |
| Buyback Yield / Dilution | -13.03% | -11.79% | -13.32% | -173.68% | -376.03% | -16.87% | |
| Total Shareholder Return | -13.03% | -11.79% | -13.32% | -173.68% | -376.03% | -16.87% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.